Literature DB >> 25943178

A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.

Y Gocho1,2, N Kiyokawa1, H Ichikawa3, K Nakabayashi4, T Osumi5, T Ishibashi1,6, H Ueno1, K Terada1,7, K Oboki8, H Sakamoto3, Y Shioda5, M Imai9, Y Noguchi7, Y Arakawa10, Y Kojima11, D Toyama12, K Hata4, T Yoshida3, K Matsumoto13, M Kato14, T Fukushima15, K Koh10, A Manabe16, A Ohara11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25943178     DOI： 10.1038/leu.2015.111

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation.

Authors:  Manuela Delvecchio; Jonathan Gaucher; Carmen Aguilar-Gurrieri; Esther Ortega; Daniel Panne
Journal:  Nat Struct Mol Biol       Date:  2013-08-11       Impact factor: 15.369

2.  RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.

Authors:  H Lilljebjörn; H Ågerstam; C Orsmark-Pietras; M Rissler; H Ehrencrona; L Nilsson; J Richter; T Fioretos
Journal:  Leukemia       Date:  2013-11-04       Impact factor: 11.528

3.  Systematic in vivo structure-function analysis of p300 in hematopoiesis.

Authors:  Erin A Kimbrel; Madeleine E Lemieux; Xiaobo Xia; Tina N Davis; Vivienne I Rebel; Andrew L Kung
Journal:  Blood       Date:  2009-10-12       Impact factor: 22.113

4.  MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).

Authors:  M Chaffanet; L Gressin; C Preudhomme; V Soenen-Cornu; D Birnbaum; M J Pébusque
Journal:  Genes Chromosomes Cancer       Date:  2000-06       Impact factor: 5.006

5.  Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13).

Authors:  K Ida; I Kitabayashi; T Taki; M Taniwaki; K Noro; M Yamamoto; M Ohki; Y Hayashi
Journal:  Blood       Date:  1997-12-15       Impact factor: 22.113

Review 6.  Acute lymphoblastic leukaemia.

Authors:  Hiroto Inaba; Mel Greaves; Charles G Mullighan
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321

7.  Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.

Authors:  Atsushi Manabe; Akira Ohara; Daisuke Hasegawa; Katsuyoshi Koh; Tomohiro Saito; Nobutaka Kiyokawa; Akira Kikuchi; Hiroyuki Takahashi; Koichiro Ikuta; Yasuhide Hayashi; Ryoji Hanada; Masahiro Tsuchida
Journal:  Haematologica       Date:  2008-06-02       Impact factor: 9.941

8.  E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia.

Authors:  C-h Zhong; V Prima; X Liang; C Frye; L McGavran; L Meltesen; Q Wei; T Boomer; M Varella-Garcia; J Gump; S P Hunger
Journal:  Leukemia       Date:  2008-01-10       Impact factor: 11.528

Review 9.  Involvement of the nuclear matrix in the control of skeletal genes: the NMP1 (YY1), NMP2 (Cbfa1), and NMP4 (Nmp4/CIZ) transcription factors.

Authors:  J P Bidwell; K Torrungruang; M Alvarez; S J Rhodes; R Shah; D R Jones; K Charoonpatrapong; J M Hock; A J Watt
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2001       Impact factor: 1.807

10.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Authors:  Laura Pasqualucci; David Dominguez-Sola; Annalisa Chiarenza; Giulia Fabbri; Adina Grunn; Vladimir Trifonov; Lawryn H Kasper; Stephanie Lerach; Hongyan Tang; Jing Ma; Davide Rossi; Amy Chadburn; Vundavalli V Murty; Charles G Mullighan; Gianluca Gaidano; Raul Rabadan; Paul K Brindle; Riccardo Dalla-Favera
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962
View more
  36 in total

1.  PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.

Authors:  Yanara Marincevic-Zuniga; Vasilios Zachariadis; Lucia Cavelier; Anders Castor; Gisela Barbany; Erik Forestier; Linda Fogelstrand; Mats Heyman; Jonas Abrahamsson; Gudmar Lönnerholm; Ann Nordgren; Ann-Christine Syvänen; Jessica Nordlund
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

Review 2.  Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Emily B Heikamp; Ching-Hon Pui
Journal:  J Pediatr       Date:  2018-09-10       Impact factor: 4.406

3.  ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.

Authors:  Shinsuke Hirabayashi; Kentaro Ohki; Kazuhiko Nakabayashi; Hitoshi Ichikawa; Yukihide Momozawa; Kohji Okamura; Akinori Yaguchi; Kazuki Terada; Yuya Saito; Ai Yoshimi; Hiroko Ogata-Kawata; Hiromi Sakamoto; Motohiro Kato; Junya Fujimura; Moeko Hino; Akitoshi Kinoshita; Harumi Kakuda; Hidemitsu Kurosawa; Keisuke Kato; Ryosuke Kajiwara; Koichi Moriwaki; Tsuyoshi Morimoto; Kozue Nakamura; Yasushi Noguchi; Tomoo Osumi; Kazuo Sakashita; Junko Takita; Yuki Yuza; Koich Matsuda; Teruhiko Yoshida; Kenji Matsumoto; Kenichiro Hata; Michiaki Kubo; Yoichi Matsubara; Takashi Fukushima; Katsuyoshi Koh; Atsushi Manabe; Akira Ohara; Nobutaka Kiyokawa
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

4.  Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.

Authors:  Takahiko Yasuda; Shinobu Tsuzuki; Masahito Kawazu; Fumihiko Hayakawa; Shinya Kojima; Toshihide Ueno; Naoto Imoto; Shinji Kohsaka; Akiko Kunita; Koichiro Doi; Toru Sakura; Toshiaki Yujiri; Eisei Kondo; Katsumichi Fujimaki; Yasunori Ueda; Yasutaka Aoyama; Shigeki Ohtake; Junko Takita; Eirin Sai; Masafumi Taniwaki; Mineo Kurokawa; Shinichi Morishita; Masashi Fukayama; Hitoshi Kiyoi; Yasushi Miyazaki; Tomoki Naoe; Hiroyuki Mano
Journal:  Nat Genet       Date:  2016-03-28       Impact factor: 38.330

5.  EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.

Authors:  Akinori Yaguchi; Takeshi Ishibashi; Kazuki Terada; Hitomi Ueno-Yokohata; Yuya Saito; Junya Fujimura; Toshiaki Shimizu; Kentaro Ohki; Atsushi Manabe; Nobutaka Kiyokawa
Journal:  Int J Hematol       Date:  2017-04-04       Impact factor: 2.490

6.  PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.

Authors:  Zhaohui Gu; Michelle L Churchman; Kathryn G Roberts; Ian Moore; Xin Zhou; Joy Nakitandwe; Kohei Hagiwara; Stephane Pelletier; Sebastien Gingras; Hartmut Berns; Debbie Payne-Turner; Ashley Hill; Ilaria Iacobucci; Lei Shi; Stanley Pounds; Cheng Cheng; Deqing Pei; Chunxu Qu; Scott Newman; Meenakshi Devidas; Yunfeng Dai; Shalini C Reshmi; Julie Gastier-Foster; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; William L Carroll; Patrick A Zweidler-McKay; Karen R Rabin; Leonard A Mattano; Kelly W Maloney; Alessandro Rambaldi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Janis Racevskis; Yanming Zhang; Ravi Bhatia; Jessica Kohlschmidt; Krzysztof Mrózek; Clara D Bloomfield; Wendy Stock; Steven Kornblau; Hagop M Kantarjian; Marina Konopleva; Williams E Evans; Sima Jeha; Ching-Hon Pui; Jun Yang; Elisabeth Paietta; James R Downing; Mary V Relling; Jinghui Zhang; Mignon L Loh; Stephen P Hunger; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-01-14       Impact factor: 38.330

7.  Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.

Authors:  Malachi Griffith; Obi L Griffith; Kilannin Krysiak; Zachary L Skidmore; Matthew J Christopher; Jeffery M Klco; Avinash Ramu; Tamara L Lamprecht; Alex H Wagner; Katie M Campbell; Robert Lesurf; Jasreet Hundal; Jin Zhang; Nicholas C Spies; Benjamin J Ainscough; David E Larson; Sharon E Heath; Catrina Fronick; Shelly O'Laughlin; Robert S Fulton; Vincent Magrini; Sean McGrath; Scott M Smith; Christopher A Miller; Christopher A Maher; Jacqueline E Payton; Jason R Walker; James M Eldred; Matthew J Walter; Daniel C Link; Timothy A Graubert; Peter Westervelt; Shashikant Kulkarni; John F DiPersio; Elaine R Mardis; Richard K Wilson; Timothy J Ley
Journal:  Exp Hematol       Date:  2016-05-13       Impact factor: 3.084

8.  Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.

Authors:  Hiroyuki Takahashi; Ryosuke Kajiwara; Motohiro Kato; Daisuke Hasegawa; Daisuke Tomizawa; Yasushi Noguchi; Kazutoshi Koike; Daisuke Toyama; Hiromasa Yabe; Michiko Kajiwara; Junya Fujimura; Manabu Sotomatsu; Setsuo Ota; Miho Maeda; Hiroaki Goto; Yoko Kato; Tetsuya Mori; Takeshi Inukai; Hiroyuki Shimada; Keitaro Fukushima; Chitose Ogawa; Atsushi Makimoto; Takashi Fukushima; Kentaro Ohki; Katsuyoshi Koh; Nobutaka Kiyokawa; Atsushi Manabe; Akira Ohara
Journal:  Int J Hematol       Date:  2018-03-27       Impact factor: 2.490

Review 9.  Beyond the coding genome: non-coding mutations and cancer.

Authors:  Kaivalya Walavalkar; Dimple Notani
Journal:  Front Biosci (Landmark Ed)       Date:  2020-06-01

10.  Identification of the immune gene expression signature associated with recurrence of high-grade gliomas.

Authors:  Adria-Jaume Roura; Bartlomiej Gielniewski; Paulina Pilanc; Paulina Szadkowska; Marta Maleszewska; Sylwia K Krol; Ryszard Czepko; Wojciech Kaspera; Bartosz Wojtas; Bozena Kaminska
Journal:  J Mol Med (Berl)       Date:  2020-11-19       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.